Spots Global Cancer Trial Database for Treatment With [90]Y-Ibritumomab Tiuxetan Versus no Treatment in Patients With Follicular Non Hodgkin Lymphoma (Stage III or IV) Having Achieved a Partial or Complete Remission After First Line Chemotherapy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Treatment With [90]Y-Ibritumomab Tiuxetan Versus no Treatment in Patients With Follicular Non Hodgkin Lymphoma (Stage III or IV) Having Achieved a Partial or Complete Remission After First Line Chemotherapy
Official Title: Efficacy and Safety of Subsequent Treatment With [90]Y-Ibritumomab Tiuxetan Versus no Further Treatment in Patients With Stage III or IV Follicular Non-Hodgkin's Lymphoma Having Achieved Partial or Complete Remission After First Line Chemotherapy. A Prospective, Multicenter, Randomized Phase III Clinical Trial
Study ID: NCT00185393
Conditions
Study Description
Brief Summary: The aim of the study is to test \[90\]Y-ibritumomab tiuxetan, a radioactive antibody, in patients with stage III or IV follicular lymphoma whose disease is in partial or complete remission after first line chemotherapy. The radioactive antibody will be compared with no further treatment to see which is better in the long term after standard lymphoma treatment.
Detailed Description: The study has previously been posted by Schering AG, Germany. Schering AG, Germany has been renamed to Bayer Schering Pharma AG, Germany. Bayer Schering Pharma AG, Germany is the sponsor of the trial.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
, Antwerpen, , Belgium
, Brugge, , Belgium
, Bruxelles, , Belgium
, Gent, , Belgium
, Leuven, , Belgium
, Yvoir, , Belgium
, Edmonton, Alberta, Canada
, Vancouver, British Columbia, Canada
, Hamilton, Ontario, Canada
, Ottawa, Ontario, Canada
, Toronto, Ontario, Canada
, Toronto, Ontario, Canada
, Montreal, Quebec, Canada
, Montreal, Quebec, Canada
, Aarhus, , Denmark
, Copenhagen, , Denmark
, Rennes, Bretagne, France
, Angers Cedex 1, , France
, Besancon, , France
, Bordeaux, , France
, Creteil, , France
, Grenoble Cedex 9, , France
, Le Mans, , France
, Lille, , France
, Lyon, , France
, Paris Cedex 15, , France
, Pierre Benite, , France
, Rouen, , France
, Strasbourg, , France
, Tours, , France
, Tübingen, Baden-Wuerttemberg, Germany
, Augsburg, Bayern, Germany
, München, Bayern, Germany
, Göttingen, Niedersachsen, Germany
, Münster, Nordrhein-Westfalen / 298, Germany
, Hamm, Nordrhein-Westfalen / 358, Germany
, Düsseldorf, Nordrhein-Westfalen, Germany
, Köln, Nordrhein-Westfalen, Germany
, Dresden, Sachsen, Germany
, Hamburg, , Germany
, Bologna, BO, Italy
, San Giovanni Rotondo, Foggia, Italy
, Milano, MI, Italy
, Milano, MI, Italy
, Rozzano, MI, Italy
, Pisa, PI, Italy
, Torino, TO, Italy
, Milano, , Italy
, Napoli, , Italy
, Palermo, , Italy
, Roma, , Italy
, Amersfoort, , Netherlands
, Amsterdam, , Netherlands
, Amsterdam, , Netherlands
, Den Haag, , Netherlands
, Eindhoven, , Netherlands
, Enschede, , Netherlands
, Groningen, , Netherlands
, Leiden, , Netherlands
, Maastricht, , Netherlands
, Nijmegen, , Netherlands
, Rotterdam, , Netherlands
, Utrecht, , Netherlands
, Zwolle, , Netherlands
, Oslo, , Norway
, Tromso, , Norway
, Coimbra, , Portugal
, Lisboa, , Portugal
, Lisboa, , Portugal
, Porto, , Portugal
, Hospitalet de Llobregat, Barcelona, Spain
, Barcelona, , Spain
, Barcelona, , Spain
, Madrid, , Spain
, Madrid, , Spain
, Malaga, , Spain
, Salamanca, , Spain
, Valencia, , Spain
, Göteborg, , Sweden
, Umeå, , Sweden
, Uppsala, , Sweden
, Zürich, Bern / 633, Switzerland
, St. Gallen, St. Gallen / 633, Switzerland
, Aarau, , Switzerland
, Bellinzona, , Switzerland
, Bern, , Switzerland
, Geneva, , Switzerland
, Lausanne, , Switzerland
, Glasgow, , United Kingdom
, London, , United Kingdom
, London, , United Kingdom
, Manchester, , United Kingdom
, Newcastle-Upon-Tyne, , United Kingdom
, Plymouth, , United Kingdom
, Surrey, , United Kingdom
Contact Details
Name: Bayer Study Director
Affiliation: Bayer
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
